Journal article · 2005
North Wales randomized controlled trial of cognitive behaviour therapy for acute schizophrenia spectrum disorders: two-year follow-up and economic evaluation
Psychological Medicine, 35(9), 1307–1316 · Published 10 August 2005 · DOI 10.1017/s0033291705005003
In brief
“North Wales randomized controlled trial of cognitive behaviour therapy for acute schizophrenia spectrum disorders: two-year follow-up and economic evaluation” is a 2005 journal article by Mike Startup and 3 co-authors, published in Psychological Medicine. OpenAlex counts 52 citations as of 20 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 52
- Most cited in
- 2012 (8)
- Field-weighted impact
- 1.33
- Authors
- 4
Abstract
BACKGROUND: There is good evidence now that cognitive behaviour therapy (CBT) is effective in the treatment of people suffering from schizophrenia. There is also some evidence that the benefits of CBT persist after the end of treatment and that the direct costs of providing CBT as an adjunct to standard care are no higher than… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Startup, M., Jackson, M. C., Evans, K. E., & Bendix, S. (2005). North Wales randomized controlled trial of cognitive behaviour therapy for acute schizophrenia spectrum disorders: two-year follow-up and economic evaluation. Psychological Medicine, 35(9), 1307–1316. https://doi.org/10.1017/s0033291705005003
MLA 9
Startup, Mike, et al. “North Wales randomized controlled trial of cognitive behaviour therapy for acute schizophrenia spectrum disorders: two-year follow-up and economic evaluation.” Psychological Medicine, vol. 35, no. 9, 2005, pp. 1307–1316. https://doi.org/10.1017/s0033291705005003.
Chicago
Startup, Mike, Mike C. Jackson, Keith E. Evans, and Sue Bendix. 2005. “North Wales randomized controlled trial of cognitive behaviour therapy for acute schizophrenia spectrum disorders: two-year follow-up and economic evaluation.” Psychological Medicine 35 (9): 1307–1316. https://doi.org/10.1017/s0033291705005003.
Harvard
Startup, M. et al. (2005) ‘North Wales randomized controlled trial of cognitive behaviour therapy for acute schizophrenia spectrum disorders: two-year follow-up and economic evaluation’, Psychological Medicine, 35(9), pp. 1307–1316. doi:10.1017/s0033291705005003.
IEEE
M. Startup, M. C. Jackson, K. E. Evans, and S. Bendix, “North Wales randomized controlled trial of cognitive behaviour therapy for acute schizophrenia spectrum disorders: two-year follow-up and economic evaluation,” Psychological Medicine, vol. 35, no. 9, pp. 1307–1316, 2005, doi: 10.1017/s0033291705005003.
BibTeX
@article{startup2005north,
title = {{North Wales randomized controlled trial of cognitive behaviour therapy for acute schizophrenia spectrum disorders: two-year follow-up and economic evaluation}},
author = {Startup, Mike and Jackson, Mike C. and Evans, Keith E. and Bendix, Sue},
journal = {Psychological Medicine},
year = {2005},
volume = {35},
number = {9},
pages = {1307--1316},
doi = {10.1017/s0033291705005003},
url = {https://doi.org/10.1017/s0033291705005003}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2012 | 8 | |
| 2013 | 3 | |
| 2014 | 3 | |
| 2015 | 1 | |
| 2016 | 2 | |
| 2017 | 4 | |
| 2018 | 2 | |
| 2019 | 3 | |
| 2020 | 2 | |
| 2021 | 1 |
Its field-weighted citation impact is 1.33: it has been cited 1.33 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- cognitive behavioral therapy
- schizophrenia
- acute psychosis
- schizophrenia spectrum disorders
- relapse prevention
- negative symptoms
- positive symptoms
- social functioning
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Startup, M., Jackson, M. C., Evans, K. E., & Bendix, S. (2005). North Wales randomized controlled trial of cognitive behaviour therapy for acute schizophrenia spectrum disorders: two-year follow-up and economic evaluation. Psychological Medicine, 35(9), 1307–1316. https://doi.org/10.1017/s0033291705005003
How many times has this paper been cited?
52 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Mike Startup, Mike C. Jackson, Keith E. Evans, Sue Bendix.
What is the DOI of this paper?
10.1017/s0033291705005003, permanently at https://doi.org/10.1017/s0033291705005003. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.